Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CIIHY | SRE |
|---|---|---|
| Price | $32.80 | $78.16 |
| Change today | ▲ 0.00% | ▼ 0.28% |
| Market cap | $51.25B | $51.11B |
| Return, 3 months | +0.5% | -16.7% |
| Return, year to date | -3.7% | -9.5% |
| Return, 1 year | -3.6% | -12.9% |
| P/E (TTM) | 8.8 | 22.6 |
| P/B | 1.1 | 1.6 |
| P/E percentile vs own 5y | – | 58th |
| Dividend yield | 3.06% | 3.33% |
| Revenue growth (YoY, latest qtr) | – | -0.1% |
| Net profit growth (YoY) | – | +81.5% |
| Gross margin | – | 49.8% |
| Operating margin | – | 25.5% |
| Net margin | – | 16.7% |
| Return on equity | – | 7.1% |
| Analyst target vs. price | – | +31.2% |
| Analyst buy share | – | 92% |
| RSI (14) | 20 | 37 |
| 30-day volatility | 21.7% | 21.1% |
| Max drawdown, 1 year | -28.4% | -21.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
